CAPLIN POINT LABORATORIES
Back to Cashflow Statement
|
CAPLIN POINT LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-38 Cr | ₹-38 Cr | ₹-28 Cr | ₹-41 Cr | ₹-24 Cr |
What is the latest Cash Flow from Financing Activities ratio of CAPLIN POINT LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-38 Cr |
| Mar2024 | ₹-38 Cr |
| Mar2023 | ₹-28 Cr |
| Mar2022 | ₹-41 Cr |
| Mar2021 | ₹-24 Cr |
How is Cash Flow from Financing Activities of CAPLIN POINT LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-38 Cr | Negative | |
| Mar2024 | ₹-38 Cr | Negative | |
| Mar2023 | ₹-28 Cr | Negative | |
| Mar2022 | ₹-41 Cr | Negative | |
| Mar2021 | ₹-24 Cr | - | |
Compare Cash Flow from Financing Activities of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹20,631.7 Cr | 6.8% | 5.6% | 25.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | 6.8% |
5.6% |
25.6% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses